Immunoselection of Breast and Ovarian Cancer Cells With Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells

Cancer Research - United States
doi 10.1158/0008-5472.can-09-0834
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Breast Cancer Stem Cells

English

Physical Intimacy of Breast Cancer Cells With Mesenchymal Stem Cells Elicits Trastuzumab Resistance Through SRC Activation

Scientific Reports
Multidisciplinary
2015English

Identification of Genes Involved in Breast Cancer and Breast Cancer Stem Cells

Breast Cancer: Targets and Therapy
Oncology
2015English

Dimensional Analysis of CD44High CD24Low and Ki67 in Triple Negative Breast Cancer

Open Access Macedonian Journal of Medical Sciences
Medicine
2019English

Epirubicin Sequential Natural Killer Cells Enhanced the Cytotoxicity to Breast Cancer Cells in Vitro

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Targeting Cancer Stem Cells With Natural Killer Cell Immunotherapy

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2016English

Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells in Vitro

PLoS ONE
Multidisciplinary
2015English

Role of Natural Killer T Cells in Immunogenic Chemotherapy for Breast Cancer

2013English

Chemo Resistance of Breast Cancer Stem Cells

2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy